J. Cosset

发表

Small-Molecule DrugsMimicking DNADamage: ANew Strategy for SensitizingTumors to Radiotherapy

L. Larue, J. Coll, N. Berthault, 2009 .

Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy

Jean-Luc Coll, Véronique Josserand, Marie Dutreix, 2009, Clinical Cancer Research.

70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial.

P. Maingon, B. Dubray, N. Salem, 2011, International journal of radiation oncology, biology, physics.

[Respiratory gated radiotherapy: the 4D radiotherapy].

P. Giraud, J. Cosset, L. Simon, 2005, Bulletin du cancer.

[Respiration-gated radiotherapy: current techniques and potential benefits].

P. Giraud, B. Dubray, J. Cosset, 2003, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Conformal Radiotherapy Planning for Lung Cancer: Analysis of Set-Up Uncertainties

P. Giraud, J. Cosset, Y. De rycke, 2007, Cancer investigation.

Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing.

J C Rosenwald, P Giraud, B Dubray, 2001, International journal of radiation oncology, biology, physics.

Second malignancies after permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003.

J. Cosset, L. Chauveinc, L. Belin, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers.

J C Rosenwald, P Giraud, E. Touboul, 2001, International journal of radiation oncology, biology, physics.

Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists.

Bernard Dubray, Vincent Servois, Philippe Giraud, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dose–Response Relationship in Permanent Implant Brachytherapy for Prostate Cancer

J. Cosset, G. Wakil, 2013 .

Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images.

A. Lalande, K. B. Girum, J. Cosset, 2018, Brachytherapy.

Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia.

J. Cosset, M. Henry-Amar, G. Socié, 1991, Blood.

[Biological equivalency of high single doses used in intraoperative irradiation].

J. Cosset, J. Dutreix, T. Girinsky, 1990, Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique.

First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma

B. Asselain, M. Dutreix, J. Grob, 2016, British Journal of Cancer.

[Respiratory gated radiotherapy: the 4D radiotherapy].

P. Giraud, J. Cosset, L. Simon, 2005, Bulletin du cancer.

Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study.

P. Giraud, B. Dubray, J. Cosset, 1996, Radiology.

In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and correlations with local control and overall survival.

A. Bernheim, R. Lubin, F. Janot, 1994, International journal of radiation oncology, biology, physics.

Hodgkin’s disease and non-Hodgkin’s lymphomas

J. Piette, J. Cosset, D. Buthiau, 1998 .

ICRP Publication 127: Radiological Protection in Ion Beam Radiotherapy

Y. Yonekura, D. Schardt, J. Hopewell, 2014 .

Focal brachytherapy for localized prostate cancer: mid-term outcomes.

J. Cosset, E. Barret, X. Cathelineau, 2021, Practical radiation oncology.

Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia

J. Binet, H. Merle-Beral, V. Leblond, 1998, Leukemia.

Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks.

R. Haas, J. Cosset, P. Solal-Céligny, 2010, International journal of radiation oncology, biology, physics.

Histopathological and cellular studies of a case of cutaneous radiation syndrome after accidental chronic exposure to a cesium source.

B. Dubray, M. Martin, J. Lefaix, 1999, Radiation research.

Molecular therapy in support to radiotherapy.

M. Dutreix, J.-S. Sun, J. Cosset, 2010, Mutation research.

Connexin 30, a new marker of hyperproliferative epidermis

D. Salomon, J. Cosset, J. Lamartine, 2006, The British journal of dermatology.

The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis.

S. Ōmura, H. Magdelenat, J. Cosset, 1998, British Journal of Cancer.

Bases biologiques de l'association chimio-radiotherapie. Applications aux cancers du poumon

J. Cosset, F. Mornex, P. V. Houtte, 1997 .

The role of radiotherapy for early stage Hodgkin's disease: limitations and perspectives.

J. Cosset, P. Mauch, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Myocardial perfusion damage after mediastinal irradiation for Hodgkin's disease: a thallium-201 single photon emission tomography study

C. Maunoury, J. Pierga, J. Cosset, 2004, European Journal of Nuclear Medicine.

Long-term toxicity of early stages of Hodgkin's disease therapy: The EORTC experience

J. Cosset, M. Henry-Amar, J. Meerwaldt, 1991 .

Pericarditis and myocardial infarctions after Hodgkin's disease therapy.

M. Tubiana, J. Cosset, M. Henry-Amar, 1991, International journal of radiation oncology, biology, physics.

Late toxicity of radiotherapy in Hodgkin's disease. The role of fraction size.

J. Cosset, M. Henry-Amar, J. Dutreix, 1988, Acta oncologica.

In response to Dr. Chan

J. Cosset, M. Antoine, M. Carette, 2002 .

Altered proliferation and differentiation of human epidermis in cases of skin fibrosis after radiotherapy.

B. Dubray, J. Lefaix, J. Cosset, 2002, International journal of radiation oncology, biology, physics.

Second cancers after radiotherapy: update and recommandations

Cyrus Chargari, J. Cosset, M. Hetnał, 2018 .

Male pattern baldness and the risk of prostate cancer.

P. Giraud, M. Yassa, Y. Rycke, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin’s disease

J. Bosq, J. Cosset, V. Ribrag, 1998, Bone Marrow Transplantation.

Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.

A. Hagenbeek, E. Noordijk, L. Bijnens, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[Risks of irradiation in hepatogastroenterology].

P. Giraud, J. Cosset, M. Henni, 2009, Presse medicale.

The French 70 Gy versus 80 Gy dose escalation trial for localized prostate cancer: feasibility and toxicity

P. Maingon, N. Salem, J. Bachaud, 2003 .

Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia.

J. Cosset, M. Henry-Amar, G. Socié, 1992, Leukemia & lymphoma.

Technical aspects of interstitial hyperthermia.

J. Cosset, E. Damiá, J. Dutreix, 1986, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Interstitial thermoradiotherapy: a technical and clinical study of 29 implantations performed at the Institut Gustave-Roussy.

A. Gerbaulet, J. Dewar, J. Cosset, 1985, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas.

J. Klijanienko, B. Dubray, H. Magdelenat, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft.

Y. Lévy, J. Cosset, J. Brouet, 1989, Blood.

Radiotherapy after ovarian transposition: ovarian function and fertility preservation.

C. Haie-meder, A. Gerbaulet, J. Cosset, 1993, International journal of radiation oncology, biology, physics.

Comparative analysis of apoptosis measured by Hoechst and flow cytometry in non-Hodgkin's lymphomas.

J. Klijanienko, B. Dubray, H. Magdelenat, 1998, Cytometry.

Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients.

A. Gerbaulet, J. Bourhis, J. Cosset, 1989, International journal of radiation oncology, biology, physics.

[Past, present and near future of techniques in radiation oncology].

P. Giraud, J. Thariat, J. Cosset, 2010, Bulletin du cancer.

Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study.

B. Dubray, B. Asselain, J. Cosset, 1995, International journal of radiation oncology, biology, physics.

Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease

M. Tubiana, J. Cosset, M. Henry-Amar, 1991, American journal of hematology.

Radiological protection in ion beam radiotherapy: practical guidance for clinical use of new technology

Y. Yonekura, D. Schardt, J. Hopewell, 2016, Annals of the ICRP.

Peripheral blood corticotropin-releasing factor, adrenocorticotropic hormone and cytokine (interleukin beta, interleukin 6, tumor necrosis factor alpha) levels after high- and low-dose total-body irradiation in humans.

M. Pallardy, H. Magdelenat, J. Cosset, 1994, Radiation research.

Thoracic CT-scanning follow-up of residual mediastinal masses after treatment of Hodgkin's disease.

J. Cosset, P. Chérel, P. Carde, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Erythrocyte Sedimentation Rate Predicts Early Relapse and Survival in Early-Stage Hodgkin Disease

E. Noordijk, M. Tubiana, J. Cosset, 1991 .

Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease.

M. Tubiana, J. Cosset, M. Henry-Amar, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The value of adjunctive radiotherapy when chemotherapy is the major curative method.

R. Arriagada, M. Tubiana, T. Chevalier, 1990, International journal of radiation oncology, biology, physics.

About «Second malignancy (SM) in prostate cancer patients treated with SBRT and other contemporary radiation techniques» by Edward Christopher Deeand colleagues.

M. Zelefsky, J. Cosset, P. Blanchard, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Role of immunosuppressive drugs for prevention of graft-v-host disease after human HLA matched bone marrow transplantation.

J. Cosset, E. Gluckman, F. Lokiec, 1987, Transplantation proceedings.

Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?

J. Bosq, J. Cosset, M. Henry-Amar, 1994, Blood.

In vivo induction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation.

B. Dubray, H. Magdelenat, J. Cosset, 1995, The British journal of radiology.

Clinical basis for TBI fractionation.

J. Cosset, J. Dutreix, E. Malaise, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term results of permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003.

J. Cosset, L. Chauveinc, L. Belin, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Prognostic factors in non-Hodgkin's lymphoma.

M. van Glabbeke, M. Tubiana, J. Cosset, 1986, International journal of radiation oncology, biology, physics.

Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival.

B. Fertil, B. Dubray, R. Lubin, 1993, International journal of radiation oncology, biology, physics.

[Hypofractionation and radiotherapy: "the eternal return"].

F. Eschwège, J. Cosset, F. Mornex, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Optimizing Combinations of Drugs and Radiation. The Interdigitated Alternating Regimen

R. Arriagada, M. Tubiana, J. Cosset, 1988 .

Sequencing of drugs and radiation. The integrated alternating regimen

R. Arriagada, M. Tubiana, J. Cosset, 1985, Cancer.

Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiation.

J. Pierga, J. Cosset, M. Henry-Amar, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Late radiation injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: emphasis on the role of exploratory laparotomy and fractionation.

E. Noordijk, J. Cosset, E. Van Der Schueren, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Blood lymphocyte subsets after the first fraction in patients given hyperfractionated total body irradiation for bone marrow transplantation.

J. Cosset, G. Socié, E. Malaise, 1991, British Journal of Cancer.

Circulating macrophage colony stimulating factor as a marker of tumour progression.

X. Sastre, J. Cosset, P. Beuzeboc, 2002, European cytokine network.

An alternating chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies: feasibility and preliminary results.

M. Tubiana, J. Cosset, M. Henry-Amar, 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: long-term follow-up.

J. Cosset, G. Socié, E. Gluckman, 1991, Blood.

Cancer of the base of the tongue: Past and future

J. Cosset, V. Mosseri, F. Brunin, 1999, Head & neck.

Alternating chemotherapy and radiotherapy combination for bulky stage I and II intermediate and high grade non-Hodgkin lymphoma: an update.

T. Vuong, M. Tubiana, J. Droz, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Single dose versus fractionated total body irradiation before bone marrow transplantation: radiobiological and clinical considerations.

B. Dubray, J. Cosset, G. Socié, 1994, International journal of radiation oncology, biology, physics.

Fractionation Sensitivity of Mammalian Tissues

B. Dubray, J. Cosset, T. Girinsky, 1994 .

Blood cell kinetics and total body irradiation.

A. Bernard, J. Cosset, J. Dutreix, 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Low-dose (one gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease.

J. Pierga, J. Cosset, H. Esperou, 1990, Transplantation.

Blood cell kinetics after a 385 cGy total body irradiation given to a CML patient for bone marrow transplantation.

J. Cosset, G. Socié, E. Malaise, 1991, Bone marrow transplantation.

The radiation accident in Georgia: clinical appearance and diagnosis of cutaneous radiation syndrome.

J. Cosset, W. Bähren, P. Gourmelon, 2000, Journal of the American Academy of Dermatology.

Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patient.

J. Pons, F. Goldwasser, J. Cosset, 1995, Leukemia & lymphoma.

Post-irradiation hyperamylasemia as a biological dosimeter.

B. Dubray, H. Thames, J. Cosset, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cancer of the base of the tongue: past and future.

J. Cosset, V. Mosseri, F. Brunin, 1999 .

Radiation injurie of the gastrointestinal tract in Hodgkin's disease: The role of exploratory laparotomy and fractionation

J. Cosset, M. Henry-Amar, M. Fayolle, 1984 .

Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning.

J C Rosenwald, P Giraud, E. Touboul, 2000, International journal of radiation oncology, biology, physics.

Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation.

E. Noordijk, B. Dubray, H. Thames, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The EORTC trials for limited stage Hodgkin's disease. The EORTC Lymphoma Cooperative Group.

M Tubiana, E. Noordijk, M. Tubiana, 1992, European journal of cancer.

Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group.

E. Noordijk, J. Cosset, M. Henry-Amar, 1990, International journal of radiation oncology, biology, physics.

Multicolor flow cytometry analysis of blood cell subsets in patients given total body irradiation before bone marrow transplantation.

E. Tartour, E. Carosella, J. Cosset, 1995, International journal of radiation oncology, biology, physics.

Prognostic factors in primary gastrointestinal non‐Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature

B. Caillou, P. Rougier, C. Théodore, 1989, Cancer.

Focal brachytherapy for selected low-risk prostate cancers: a pilot study.

J. Cosset, E. Barret, D. Prapotnich, 2013, Brachytherapy.

Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma: the 1975-1980 EORTC controlled lymphoma trial.

M. van Glabbeke, M. Glabbeke, J. Cosset, 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Risk of secondary acute leukemia and preleukemia after Hodgkin's disease: the Institut Gustave-Roussy experience.

M. Tubiana, J. Cosset, M. Henry-Amar, 1989, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[Diagnostic value of vaginal mouldings in uterine cancer (author's transl)].

J. Cosset, A. Gerbaulet, D. Chassagne, 1979, Journal de radiologie.

Patient Selection and Recommendations on Permanent Seed Implantation as Monotherapy for Localized Prostate Cancer

J. Cosset, J. Hannoun-levi, 2013 .

Ionizing radiation to prevent arterial intimal hyperplasia at the edges of the stent: induces necrosis and fibrosis.

C. Creusy, F. Eschwège, E. Ducasse, 2006, The Journal of surgical research.

Morphometric and histological changes in the vascular wall after external radiation for the prevention of intimal hyperplasia.

F. Eschwège, E. Ducasse, P. Puppinck, 2004, The Journal of surgical research.

Is there any benefit to particles over photon radiotherapy?

D. Verellen, G. Storme, T. Gevaert, 2019, Ecancermedicalscience.

COVID-19-Associated Pneumonia: Radiobiological Insights

Cyrus Chargari, J. Cosset, M. Drouet, 2021, Frontiers in Pharmacology.

Single dose versus hyperfractionated total body irradiation before allogeneic bone marrow transplantation: a non-randomized comparative study of 54 patients at the Institut Gustave-Roussy.

J. Cosset, B. Shank, J. Dutreix, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies.

J. Bourhis, J. Cosset, G. Socié, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Follow-Up Consultation as Cheap as a Postage Stamp

Cyrus Chargari, J. Cosset, F. Campana, 2010, Urologia Internationalis.

[The issue of low doses in radiation therapy and impact on radiation-induced secondary malignancies].

Cyrus Chargari, J. Cosset, 2013, Bulletin du cancer.

Increased sensitivity of CLL‐derived lymphocytes to apoptotic death activation by the proteasome‐specific inhibitor lactacystin

S Omura, F Mentz, S. Ōmura, 1999, British journal of haematology.

Consequences of two different doses to the lungs during a single dose of total body irradiation: results of a randomized study on 85 patients.

J. Cosset, G. Socié, E. Gluckman, 1994, International journal of radiation oncology, biology, physics.

Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: is there a best choice? SFGM. Société Française de Greffe de Moelle.

D. Blaise, D. Cowen, J. Reiffers, 1995, International journal of radiation oncology, biology, physics.

Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?

M. Roach, M. Bolla, D. Peiffert, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Prospective study of the clinical symptoms of therapeutic whole body irradiation.

B. Dubray, J. Cosset, G. Socié, 1993, Health physics.

Clinical applications of proton therapy

J. Habrand, L. Schwartz, J. Cosset, 1995, Radiation and environmental biophysics.

The never-ending controversy about TBI schedules.

J. Cosset, G. Socié, T. Girinsky, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Embryonal rhabdomyosarcoma of the vagina in children: conservative treatment with curietherapy and chemotherapy.

J. Cosset, J. Lemerle, F. Flamant, 1979, European journal of cancer.

Focal radiotherapy as focal therapy of prostate cancer

B. Carey, J. Cosset, G. Kovács, 2014, Current opinion in urology.

Morbidity of focal therapy in the treatment of localized prostate cancer.

P. Validire, J. Cosset, E. Barret, 2013, European urology.

[Evaluation and results of ablative therapies in prostate cancer].

A. Gangi, H. Lang, J. Cosset, 2017, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Is proton beam therapy the future of radiotherapy? Part I: clinical aspects].

J. Habrand, J. Cosset, P. Bey, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: long-term results for 96 patients with tumors > 5 cm.

S. Koscielny, J. Bosq, J. Cosset, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

The contribution of clinical trials to the treatment of patients with early stages of Hodgkin's disease.

M. Tubiana, J. Cosset, M. Henry-Amar, 1986, Drugs under experimental and clinical research.

Current trend in the treatment of Hodgkin's disease.

M. Tubiana, J. Droz, J. Cosset, 1983, Radiation medicine.

Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies

J. Bourhis, J. Cosset, G. Socié, 2001 .

Unusual localization of cutaneous chronic graft-versus-host disease in the radiation fields in four cases.

J. Cosset, H. Esperou, G. Socié, 1989, Bone marrow transplantation.

ESTRO Breur Gold Medal Award Lecture 2001: irradiation accidents-- lessons for oncology?

J. Cosset, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Blood amylase: a biological marker in irradiation accidents? Preliminary results obtained at the Gustave-Roussy Institut (GRI) and a literature review].

J. Cosset, C. Hennequin, J. Dutreix, 1989, Bulletin du cancer.

BRACHYTHERAPY: A LIFESAVING TREATMENT THAT NEEDS TO PROTECT THE CAREGIVERS THAT DELIVER THE THERAPY

B. Thomadsen, L. Dauer, P. Scalliet, 2021 .

Occupational Radiological Protection in Brachytherapy

B. Thomadsen, L. Dauer, P. Scalliet, 2021, Annals of the ICRP.

Prevention of radiation-induced cancers

Cyrus Chargari, J. Cosset, T. Lacornerie, 2021, Cancer/Radiothérapie.

Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: Defective rejoining of radioinduced dna strand breaks in lymphocytes of breast cancer patients

E. Moustacchi, J. Cosset, C Alapetite, 1999, International journal of cancer.

Potential role for low dose limited‐field radiation therapy (2 × 2 grays) in advanced low‐grade non‐Hodgkin's lymphomas

P. Lambin, J. Bosq, J. Cosset, 1994, Hematological oncology.

Prostate cancer brachytherapy: SFRO guidelines 2021.

D. Peiffert, J. Cosset, J. Hannoun-Lévi, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment.

S. Koscielny, J. Bosq, J. Cosset, 2001, International journal of radiation oncology, biology, physics.

Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models?

N. Magné, Cyrus Chargari, K. Goodman, 2016, Cancer and Metastasis Reviews.

Fragmentation of dinucleotides d(ApAp) following K shell ionization of phosphorus atom by monochromatic soft X-rays

J. Cosset, M. Maire, H. Frohlich, 1995 .

[The dawn of radiotherapy, between strokes of genius, dramas and controversies].

J. Cosset, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Biologic and anatomic problems of lung shielding in whole-body irradiation.

J. Cosset, J. Dutreix, A. Bridier, 1986, Journal of the National Cancer Institute.

Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?

K. Rosenzweig, P. Giraud, B. Milleron, 2006, International journal of radiation oncology, biology, physics.

Focal brachytherapy for localized prostate cancer: Urinary toxicity depends on tumor location.

M. Baghdadi, J. Cosset, E. Barret, 2017, Brachytherapy.

[Hodgkin's disease. Long-term complications of radiotherapy].

J. Cosset, M. Henry-Amar, 1997, Presse medicale.

[Secondary solid tumors after Hodgkin's disease radiotherapy; experience at the Gustave Roussy Institute].

M. Tubiana, J. Cosset, M. Henry-Amar, 1992, Bulletin du cancer.

[Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?]

J. Cosset, J. Mazeron, C. Chargari, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models?

N. Magné, Cyrus Chargari, K. Goodman, 2016, Cancer and Metastasis Reviews.

Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study.

Pascal Pommier, Didier Peiffert, N. Salem, 2007, International journal of radiation oncology, biology, physics.

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity.

P. Maingon, B. Dubray, N. Salem, 2004, International journal of radiation oncology, biology, physics.

Is the linear no-threshold (LNT) model relevant for radiotherapy?

J. Cosset, 2022, Radioprotection.

Combined interstitial hyperthermia and brachytherapy: Institute Gustave Roussy technique and preliminary results.

J. Cosset, E. Damiá, J. Dutreix, 1984, International journal of radiation oncology, biology, physics.

[Permanent implant prostate cancer brachytherapy].

J. Cosset, L. Chauveinc, G. Vallancien, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Treatment of multiple myeloma by high dose chemotherapy, total body irradiation and autologous blood stem cell autograft.

Y. Lévy, J. Cosset, J. Brouet, 1989, Nouvelle revue francaise d'hematologie.

[Iodin 125 seed migration after prostate brachytherapy: a study of 170 patients].

J. Cosset, L. Chauveinc, A. Savignoni, 2004, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Follow-up thallium-201 scintigraphy after mantle field radiotherapy for Hodgkin's disease.

C. Maunoury, J. Pierga, J. Cosset, 1993, International journal of radiation oncology, biology, physics.

Prostate cancer brachytherapy: is real-time ultrasound-based dosimetry predictive of subsequent CT-based dose distribution calculation? A study of 450 patients by the Institut Curie/Hospital Cochin (Paris) Group.

J. Cosset, L. Chauveinc, J. Rosenwald, 2004, International journal of radiation oncology, biology, physics.

ICRP publication 112. A report of preventing accidental exposures from new external beam radiation therapy technologies.

J C Rosenwald, P Dunscombe, P. Dunscombe, 2009, Annals of the ICRP.

Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients.

B. Asselain, J. Cosset, L. Chauveinc, 2008, International journal of radiation oncology, biology, physics.

[Side effects of ionizing radiation on healthy tissues and organs at risk].

J. Cosset, 2010, Cancer Radiothérapie.

Accuracy in mantle field irradiations: irradiated volume and daily dose

F. Eschwège, C. Weltens, J. Cosset, 1994 .

Accuracy in mantle field irradiations: irradiated volume and daily dose.

F. Eschwège, C. Weltens, J. Cosset, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Post-brachytherapy transurethral resection of the prostate in patients with localized prostate cancer.

M. Peyromaure, J. Cosset, L. Chauveinc, 2004, The Journal of urology.

Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience. EORTC Lymphoma Cooperative Group.

J. Cosset, M. Henry-Amar, J. H. Meerwaldt, 1991, Annals of Oncology.

[the role of radiotherapy for limited stage Hodgkin's disease in 1999: limitations and perspectives].

J. Cosset, M. Henry-Amar, P. Carde, 1999, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Which alpha/beta ratio for prostate cancer in 2019?]

Cyrus Chargari, J. Cosset, G. Créhange, 2019, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Therapeutic problems in 2 patients with Hodgkin's disease and HIV 1 positive serology].

J. Cosset, G. Socié, G. Tchernia, 1988, Bulletin du cancer.

Linitis plastica after Hodgkin's disease

J. Cosset, M. Henry-Amar, P. Dietrich, 1993, The Lancet.

PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup.

J. Cosset, L. Chauveinc, J. Rosenwald, 2006, Brachytherapy.

[PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure].

J. Cosset, L. Chauveinc, J. Rosenwald, 2007, Cancer Radiothérapie.

Clinical original contributionFractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: Is there a best choice?☆

D. Blaise, D. Cowen, J. Reiffers, 1995 .

In vitro radiation-induced apoptosis and tumour response to radiotherapy: a prospective study in patients with non-Hodgkin lymphomas treated by low-dose irradiation.

J. Klijanienko, B. Dubray, H. Magdelenat, 1997, International journal of radiation biology.

Chemoradiotherapy for localized non-Hodgkin's lymphoma.

J. Cosset, 1998, The New England journal of medicine.

ICRP Publication 127: Radiological Protection in Ion Beam Radiotherapy.

Y. Yonekura, D. Schardt, J. Hopewell, 2014, Annals of the ICRP.

[A quality control program for radiotherapy in Hodgkin's disease].

J. Cosset, C. Hennequin, C. Carrie, 1999, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Salvage radiotherapy guided by functional imaging for macroscopic local recurrence following radical prostatectomy: A multicentric retrospective study.

J. Cosset, D. Pasquier, G. Francolini, 2022, Journal of Clinical Oncology.

The prognostic significance of large mediastinal masses in the treatment of Hodgkin's disease. The experience of the institut gustave‐roussy

M. Tubiana, J. Cosset, M. Henry-Amar, 1984, Hematological oncology.

Combined Modality Treatment for Poor Prognosis Stages I and II Hodgkin's Disease.

E. Noordijk, B. Dubray, J. Cosset, 1996, Seminars in radiation oncology.

One-step customized transurethral resection of the prostate and permanent implant brachytherapy for selected prostate cancer patients: technically feasible but too toxic.

J. Cosset, E. Barret, X. Cathelineau, 2011, Brachytherapy.

[Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]].

J. Cosset, E. Mouret‐Fourme, P. Beuzeboc, 2002, Cancer Radiothérapie.

Thallium-201 scintigraphy is not predictive of late cardiac complications in patients with Hodgkin's disease treated with mediastinal radiation.

J. Pierga, A. Rey, J. Cosset, 2000, International journal of radiation oncology, biology, physics.

Hodgkins disease

B. Fervers, C. Sebban, F. Giammarile, 2001, British Journal of Cancer.

Technical basis for the application of localized hyperthermia.

J. Cosset, J. Dutreix, S. Faria, 1983, Strahlentherapie.

A lost pigtail

J. Cosset, K. M. Sheibani, C. Sharp, 1999, Journal of the Royal Society of Medicine.

[Late effects of radiation on normal tissues].

B. Dubray, J. Cosset, L. Chauveinc, 1994, La Revue du praticien.

New Considerations On the Application of the Lq Model To the Interpretation of Absorbed Dose Distribution in the Daily Practice of Radiotherapy

A. Wambersie, P. Scalliet, J. Cosset, 1992 .

[High-dose external ionizing radiation prevents intimal hyperplasia and limits secretion of growth factors PDGFbb, bFGF, and TGFb1. Experiments and results].

F. Eschwège, E. Ducasse, P. Puppinck, 2003, Journal des maladies vasculaires.

Estimation of clonogenic cell fraction in primary cultures derived from human squamous cell carcinomas.

B. Dubray, N. Chavaudra, W. Brock, 1991, International journal of radiation oncology, biology, physics.

Chronological changes in morphometry and histology in the rabbit vascular wall after external radiation for the prevention of intimal hyperplasia.

C. Creusy, F. Eschwège, E. Ducasse, 2005, The Journal of surgical research.

External Beam Ionizing Radiation for Inhibition of Myointimal Hyperplasia after Dilatation and Anastomoses: Experimental Models and Results

C. Creusy, F. Eschwège, E. Ducasse, 2004, Annals of vascular surgery.

Les indications de la curiethérapie de prostate par implantation permanente

J. Cosset, J. Rosenwald, L. Chauveinc, 2002 .

Radiobiological and Clinical Bases for Total Body Irradiation in the Leukemias and Lymphomas.

B. Dubray, J. Cosset, G. Socié, 1995, Seminars in radiation oncology.

J. Cosset, G. Socié, J. Dutreix, 1990, British Journal of Cancer.

[Pulmonary toxicity of antimitotic agent-radiotherapy combination].

J. Cosset, P. Carde, G. Tchernia, 1986, Therapie.

Clinical Efficacy of Irradiation in CLL Patients: Predictive Value of in Vitro Radio-induced Apoptosis

B. Dubray, E. Blot, J. Cosset, 2002, Leukemia & lymphoma.

Electron beam irradiation of conjunctival lymphomas.

J. Cosset, E. Briot, T. Girinsky, 1991, International journal of radiation oncology, biology, physics.

[Malignant non-Hodgkin's lymphoma of the conjunctiva. Apropos of 14 cases treated at the Institut Gustave-Roussy].

J. Droz, J. Cosset, E. Briot, 1990, Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique.

[Which photon energy for intensity-modulated radiotherapy and volumetric-modulated arctherapy in 2019?]

J. Cosset, M. Nassef, J. Cosset, 2019, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Which alpha/beta ratio for prostate cancer in 2019?]

Cyrus Chargari, J. Cosset, J. Cosset, 2019, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Radiation toxicity to the heart: physiopathology and clinical data].

P. Giraud, J. Cosset, 2004, Bulletin du cancer.

[Hypofractionated irradiation of prostate cancer: What is the radiobiological understanding in 2017?]

J. Cosset, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Clinical value of the potential doubling time (Tpot) measured by flow cytometry].

B. Dubray, J. Cosset, N. Terry, 1995, Bulletin du cancer.